Antimicrobial Activity and Integrated In Silico Evaluation of Bioactive Constituents from Trametes versicolor against Clinically Isolated Pathogens
This study demonstrates that sawdust supplementation significantly enhances the yield of *Trametes versicolor*, whose methanol extract exhibits potent antimicrobial activity against clinically isolated pathogens, with integrated in silico analyses identifying specific bioactive constituents as promising leads for targeting bacterial DNA gyrase B.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
In the ongoing battle against infections that no longer respond to standard medicines, scientists are turning back to nature for new solutions. For decades, researchers have known that fungi, particularly mushrooms, produce a vast array of chemical compounds to defend themselves in the wild. These natural substances often have the ability to stop bacteria and other harmful microbes from growing. One such fungus, known as the turkey tail mushroom, has long been studied for its medicinal properties, but scientists are now looking deeper into its specific chemical makeup to find new ways to fight drug-resistant bacteria. The challenge lies in identifying which specific molecules within the mushroom are the most effective and understanding how they might work inside the human body without causing harm. This requires a careful blend of growing the fungus, testing its extracts against dangerous germs, and using powerful computer models to predict how the best candidates might behave.
A team of researchers in Nigeria set out to explore this potential using a comprehensive approach that combined traditional laboratory work with advanced computer simulations. They began by cultivating the turkey tail mushroom on two different types of sawdust mixtures. One mixture was plain, while the other was enriched with nutrients like sorghum grain and wheat bran. The results were striking: the nutrient-rich environment allowed the mushrooms to grow much faster and produce significantly more biomass. While the plain sawdust yielded just over 100 grams of fresh mushrooms, the enriched mix produced nearly 374 grams, a more than threefold increase in harvest. This extra biomass provided the necessary material for the next stage of the study, where the researchers dried and ground the mushrooms into a powder to extract their chemical contents.
The team then tested three different liquids to pull the active compounds out of the mushroom powder: water, ethanol, and methanol. Interestingly, the liquid that recovered the most total mass was water, but it was the methanol extract that proved to be the most powerful against the germs. The researchers tested these extracts against five different types of clinically isolated pathogens, including common bacteria like Staphylococcus aureus and Escherichia coli, as well as a yeast called Candida albicans. The methanol extract showed the strongest ability to stop the growth of these microbes, creating the largest zones of inhibition in their tests. The most effective result was seen against Staphylococcus aureus, where the extract stopped bacterial growth across a zone measuring 22.33 millimeters. This finding highlighted that simply extracting more material does not guarantee more potency; the type of solvent used determines which chemical compounds are recovered, and in this case, methanol captured the most effective antimicrobial agents.
To understand what was inside that powerful methanol extract, the scientists used a technique called gas chromatography-mass spectrometry, which separates and identifies the individual chemicals within a mixture. They found a complex blend dominated by terpenoids, a class of organic compounds often found in plants and fungi that are known for their biological activity. The most abundant compound they identified was a specific oxygenated molecule, followed by several other terpenes and aromatic compounds. With this chemical profile in hand, the researchers moved to the computer to see how these specific molecules might interact with a known target in bacteria. They chose to focus on a protein called DNA gyrase B, which is essential for bacteria to copy their genetic material and divide. If a molecule can block this protein, it can stop the bacteria from multiplying.
Using sophisticated modeling software, the team simulated how the top candidates from the mushroom extract would fit into the active site of this bacterial protein. They compared these natural compounds to a known antibiotic called novobiocin, which is already used to treat infections. Among the mushroom-derived molecules, one specific compound, identified by the code CID 5281515, showed the strongest predicted binding to the bacterial target, performing nearly as well as the established antibiotic in the simulation. To ensure this molecule would not only bind well but also remain stable and safe, the researchers ran extensive computer simulations over a period of 200 nanoseconds. These simulations tracked the movement of the molecule and the protein over time, revealing that the leading candidate maintained a stable and consistent connection with the target, unlike some other molecules that wobbled or drifted away.
The study also checked the safety profile of these top candidates using computer predictions to see how they might be absorbed and processed by the human body. The results suggested that the most promising molecule could be absorbed well by the intestines and might even cross into the brain, while showing no signs of being toxic or mutagenic in the models. This combination of strong binding, stability, and favorable safety predictions points to this specific mushroom compound as a serious candidate for further development. The researchers concluded that while the work so far is a mix of lab experiments and computer modeling, the evidence is strong enough to warrant the next step: isolating this specific compound in pure form and testing it directly against bacteria and the target protein in a real-world setting. This integrated approach, from growing the mushroom to simulating its molecular behavior, offers a clear and promising path forward in the search for new antimicrobial agents to combat resistant infections.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.